VALIANT - Valsartan,captopril nebo obojí u infarktu myokardu komplikovaného srdečním selháním a/nebo dysfunkcí levé komory - samostatně ano,společně ne

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	VALIANT - Valsartan, captopril, nad combination with myocardial infartion
Authors	VÍTOVEC Jiří ŠPINAR Jindřich
Year of publication	2004
Type	Article in Periodical
Magazine / Source	Klinická farmakologie a farmacie
MU Faculty or unit	Faculty of Medicine
Citation
Field	Cardiovascular diseases incl. cardiosurgery
Keywords	Valsartan;captorpil;myocardial infarction
Description	Study VALIANT is double-blind trial compared the effect of the valsartan, captopril, nad combination of the two on mortality among patients with myocardial infartion com-plicated by left ventricular systolic dysfunction (MI with LVSD). Conlcusion :valsartan is as effective as captopril in patients with MI and LVSD. Combination valsartan and captopril increased the rate of adverse events without improving survival
Related projects:	Early diagnostics of Cardiovascular Diseases